Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Verri

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Microarrays (Basel, Switzerland)|September 8, 2016
MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA SignatureOrazio Fortunato, Carla Verri, Ugo Pastorino, et al.
Biomed Research International|October 14, 2014
Therapeutic use of microRNAs in lung cancerOrazio Fortunato, Mattia Boeri, Carla Verri, et al.
BMC Genomics|October 24, 2015
Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCRDavide Conte, Carla Verri, Cristina Borzi, et al.
Expert Review of Molecular Diagnostics|May 1, 2015
Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imagingMattia Boeri, Stefano Sestini, Orazio Fortunato, et al.
Molecules (Basel, Switzerland)|March 13, 2014
Assessment of circulating microRNAs in plasma of lung cancer patientsOrazio Fortunato, Mattia Boeri, Carla Verri, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2008
Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective studyGabriella Sozzi, Luca Roz, Davide Conte, et al.
Journal of Visualized Experiments : Jove|November 21, 2017
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer ScreeningMavis Mensah, Cristina Borzi, Carla Verri, et al.
Lung Cancer (Amsterdam, Netherlands)|September 12, 2009
Plasma DNA levels in spiral CT-detected and clinically detected lung cancer patients: a validation analysisLuca Roz, Carla Verri, Davide Conte, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancerMattia Boeri, Carla Verri, Davide Conte, et al.
Oncotarget|November 1, 2019
Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningStefano Sestini, Mattia Boeri, Alfonso Marchiano, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Microarrays (Basel, Switzerland)|September 8, 2016
MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA SignatureOrazio Fortunato, Carla Verri, Ugo Pastorino, et al.
Biomed Research International|October 14, 2014
Therapeutic use of microRNAs in lung cancerOrazio Fortunato, Mattia Boeri, Carla Verri, et al.
BMC Genomics|October 24, 2015
Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCRDavide Conte, Carla Verri, Cristina Borzi, et al.
Expert Review of Molecular Diagnostics|May 1, 2015
Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imagingMattia Boeri, Stefano Sestini, Orazio Fortunato, et al.
Molecules (Basel, Switzerland)|March 13, 2014
Assessment of circulating microRNAs in plasma of lung cancer patientsOrazio Fortunato, Mattia Boeri, Carla Verri, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2008
Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective studyGabriella Sozzi, Luca Roz, Davide Conte, et al.
Journal of Visualized Experiments : Jove|November 21, 2017
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer ScreeningMavis Mensah, Cristina Borzi, Carla Verri, et al.
Lung Cancer (Amsterdam, Netherlands)|September 12, 2009
Plasma DNA levels in spiral CT-detected and clinically detected lung cancer patients: a validation analysisLuca Roz, Carla Verri, Davide Conte, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancerMattia Boeri, Carla Verri, Davide Conte, et al.
Oncotarget|November 1, 2019
Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningStefano Sestini, Mattia Boeri, Alfonso Marchiano, et al.
Pageof 2